GF Fermentech, a subsidiary company of GenoFocus, produces bioactive materials with core technologies based on strain development, fermentation, biotransformation, purification, and formulation. Over the past 20 years, we have been developing the best performing microbial strains and highly specialized extraction, purification, and formulation technologies, and we have been supplying the best-in-class bioactive materials such as Vitamin K2 MK7, Nattokinase, Lactobionic acid and phytoshingosine. GF Fermentech has dived into synthetic biology field for industrial production of renewable and sustainable bio-products. GF Fermentech holds several platform hosts for strain development, each with its own proprietary genetic set of tools and fermentation techniques for biochemicals such as retinol, phytoene, specialty proteinases etc which are produced usually by chemical synthesis or exists a little in nature. Each optimized strain can be utilized for the production of specific biochemical materials at the highest efficiency. GF Fermentech is continually expanding platform microbes In addition to strain development, as a vertically integrated biotech company, we can rapidly scale-up our strains which will be the best at what they do to produce target bioactive materials to tens of tons scale at the highest level of quality. GF Fermentech will continue to expand our business portfolio through distinct strain discovery and improvement, fermentation, purification, and formulation technology. Email: gftinfo@genofocus.com
View Top Employees from GF FERMENTECH Inc. / 지에프퍼멘텍Website | http://www.gffermentech.com |
Employees | 21 (9 on RocketReach) |
Founded | 2000 |
Industry | Biotechnology Research |
Looking for a particular GF FERMENTECH Inc. / 지에프퍼멘텍 employee's phone or email?
Jeong Han is the CEO of GF FERMENTECH Inc. / 지에프퍼멘텍.
9 people are employed at GF FERMENTECH Inc. / 지에프퍼멘텍.